Showing results (131-140 of 176) with videos related to

Sort By:
Pageof 18
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 7, 2026
The impact of BRCA status on the efficacy of paclitaxel monotherapy in recurrent ovarian cancerGiorgia Russo, Adriana Ionelia Apostol, Ilary Ruscito, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 11, 2026
Intermittent olaparib with neoadjuvant platinum-based chemotherapy in BRCA-mutated un-resectable ovarian cancer: the NUVOLA trialVanda Salutari, Claudia Marchetti, Elena Giudice, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 2, 2025
Comprehensive genomic profiling and clinico-pathologic characterization of primary ovarian leiomyosarcomaMatteo Bruno, Elisa De Paolis, Angelo Minucci, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 10, 2025
Failure of early interval debulking surgery after standard neoadjuvant chemotherapy: May bevacizumab add something? A large retrospective studyRaffaella Ergasti, Laura Vertechy, Ilary Ruscito, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|August 14, 2023
Origin of Residual Tumor Masses in BRCA1/2-Driven Ovarian Carcinomas Treated by Neoadjuvant Chemotherapy: Selection of Preexisting BRCA1/2-Proficient Tumor Cells but Not the Gain of Second ORF-Restoring MutationAnna Sokolenko, Elena Preobrazhenskaya, Claudia Marchetti, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|April 16, 2022
Needleoscopic-assisted risk-reducing bilateral salpingo-oophorectomy in BRCA1/2 mutation carriers: Peri-operative outcomes and psychological impactAndrea Rosati, Camilla Fedele, Anna Fagotti, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 22, 2018
Impact of Hormone Receptor Status and Ki-67 Expression on Disease-Free Survival in Patients Affected by High-risk Endometrial CancerViolante Di Donato, Valentina Iacobelli, Michele Carlo Schiavi, et al.
Chemotherapy|October 31, 2016
Bevacizumab in Ovarian Cancer: State of the Art and Unanswered QuestionsAngela Musella, Laura Vertechy, Alessia Romito, et al.
British Journal of Pharmacology|July 24, 2025
A procedure to identify persistent and effort-independent individual differences in preference for heroin over rewarding social interactionGinevra D'Ottavio, Alana Sullivan, Sara Pezza, et al.
Bioengineering & Translational Medicine|April 22, 2026
Engineering ovarian tissue via biofabrication and 3D bioprinting: Challenges and emerging perspectivesChieh En Hsu, Mario Mazza, Giordano Perini, et al.
Pageof 18